Beneficial effect of the polysaccharides from bupleurum smithii var. parvifolium on "Two-Hit" acute lung injury in rats

Inflammation

Volumn 35, Issue 5, 2012, Pages 1715-1722

  Cheng, Xiao Qin ^a   Song, Lu Jin ^a   Li, Hong ^a,b   Di, Hongye ^a   Zhang, Yun Yi ^a   Chen, Dao Feng ^a,b  

^a FUDAN UNIVERSITY   (China)

^b NONE   (China)

Author keywords

Acute lung injury; Bupleurum smithii var. Parvifolium; Complement; Cytokine; Inflammation; Polysaccharides

Indexed keywords

BUPLEURUM POLYSACCHARIDE; COMPLEMENT COMPONENT C3; DEXAMETHASONE; INTERLEUKIN 6; MYELOPEROXIDASE; POLYSACCHARIDE; PROTEIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BUPLEURUM; BUPLEURUM SMITHII PARVIFOLIUM; CHEMICAL PARAMETERS; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DISEASE MODEL; DRUG DOSE COMPARISON; DRUG MECHANISM; HEMOLYSIS; HEMORRHAGIC SHOCK; ISOLATION PROCEDURE; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; MEDIATOR RELEASE; NONHUMAN; PLANT ROOT; RAT; REPERFUSION; VARIETAS; WET TO DRY WEIGHT RATIO; WISTAR RAT;

BUPLEURUM SMITHII; RATTUS; RATTUS NORVEGICUS;

EID: 84866742771     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9489-7     Document Type: Article

References (29)

1. Chu, C.H., D.D. Liu, Y.H. Hsu, K.C. Lee, and H.I. Chen. 2007. Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats. Pulmonary Pharmacology and Therapeutics 20: 503-512.
2. Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: Four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319-327.
3. Yeh, C.C., C.C. Lin, S.D. Wang, Y.S. Chen, B.H. Su, and S.T. Kao. 2006. Protective and anti-inflammatory effect of a traditional Chinese medicine Xia-Bai-San, by modulating lung local cytokine in a murine model of acute lung injury. International Immunopharmacology 6: 1506-1514.
4. Jacob, H.S., P.R. Craddock, D.E. Hammerschmidt, and C.F. Moldow. 1980. Complement-induced granulocyte aggregation: An unsuspected mechanism of disease. New England Journal of Medicine 302: 789-794.
5. Hammerschmidt, D.E., L.J. Weaver, L.D. Hudson, P.R. Craddock, and H.S. Jacob. 1980. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Lancet 1: 947-949.
6. Weigelt, J.A., D.E. Chenoweth, K.R. Borman, and J.F. Norcross. 1988. Complement and the severity of pulmonary failure. The Journal of Trauma 28: 1013-1019.
7. Hutchison, J. 2000. Neutrophils in sepsis, septic shock, and adult respiratory distress syndrome: How stiff is too stiff? Critical Care Medicine 28: 2659-2660.
8. Zhao, R.Z., S.J. Liu, S.R. Mao, and Y.J. Wang. 2009. Study on liver targeting effect of vinegar-baked Radix Bupleuri on resveratrol in mice. Journal of Ethnopharmacology 126: 415-420.
9. Ikegami, F., M. Sumino, Y. Fujii, T. Akiba, and T. Satoh. 2006. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Human & Experimental Toxicology 25: 481-494.
10. Wang, Z., H. Li, H. Xu, X.L. Yue, X.Q. Cheng, W.J. Hou, Y.Y. Zhang, and D.F. Chen. 2009. Beneficial effect of Bupleurum polysaccharides on autoimmune disease induced by Campylobacter jejuni in BALB/c mice. Journal of Ethnopharmacology 124: 481-487.
11. Cheng, X.Q., H. Li, X.L. Yue, J.Y. Xie, Y.Y. Zhang, H.Y. Di, and D.F. Chen. 2010. Macrophage immunomodulatory activity of the polysaccharides from the roots of Bupleurum smithii var. parvifolium. Journal of Ethnopharmacology 130: 363-368.
12. Xu, H., Y.Y. Zhang, J.W. Zhang, and D.F. Chen. 2007. Isolation and characterization of an anti-complementary polysaccharide D3-S1 from the roots of Bupleurum smithii. International Immunopharmacology 7: 175-182.
13. Fan, J., J.C. Marshall, M. Jimenez, P.N. Shek, J. Zagorski, and O.D. Rotstein. 1998. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: Role in pulmonary inflammation following lipopolysaccharide. Journal of Immunology 161: 440-447.
14. Yoshinari, D., I. Takeyoshi, Y. Koibuchi, K. Matsumoto, Y. Kawashima, T. Koyama, S. Ohwada, and Y. Morishita. 2001. Effects of a dual inhibitor of tumor necrosis factor-α and interleukin-1 on lipopolysaccharide-induced lung injury in rats: Involvement of the p38 mitogen-activated protein kinase pathway. Critical Care Medicine 29: 628-634.
15. Betsuyaku, T., J.M. Shipley, Z. Liu, and R.M. Senior. 1999. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. American Journal of Respiratory Cell and Molecular Biology 20: 1303-1309.
16. Yoko, I., B. Tomoko, N. Katsura, N. Yasuyuki, and N. Masaharu. 2005. Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. Experimental Gerontology 40: 315-323.
17. Nahum, A., A. Adina, M. Eliau, R. Ishay, D. Shlomit, and K. Tamar. 2009. Inhalation exposure to sulfur mustard in the guinea pig model: Clinical, biochemical and histopathological characterization of respiratory injuries. Toxicology and Applied Pharmacology 241: 154-162.
18. Moore, F.A., and E.E. Moore. 1995. Evolving concepts in the pathogenesis of postinjury multiple organ failure. The Surgical Clinics of North America 75: 257-277.
19. Zhang, H., and G.Y. Sun. 2005. LPS induces permeability injury in lung microvascular endothelium via AT1 receptor. Archives of Biochemistry and Biophysics 441: 75-83.
20. Lang, J.D., and J.M. Hickman-Davis. 2005. One-hit, two-hit*is there really any benefit? Clinical and Experimental Immunology 141: 211-214.
21. Rotstein, O.D. 2003. Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. The Journal of Trauma 54: 203-206.
22. Tamandl, D., M. Bahrami, B. Wessner, G. Weigel, M. Ploder, W. Furst, E. Roth, G. Boltz-Nitulescu, and A. Spittler. 2003. Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: Tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity. Shock 20: 224-229.
23. Rocco, P.R.M., D.P. Momesso, R.C. Figueira, H.C. Ferreira, R.A. Cadete, A. Legora-Machado, V.L.G. Koatz, L.M. Lima, E.J. Barreiro, andW.A. Zin. 2003. Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury. European Respiratory Journal 22: 20-27.
24. Niwa,M., A. Hara, Y. Kanamori, D. Hatakeyama,M. Saio, T. Takami, H. Matsuno, O. Kozawa, and T. Uematsu. 2000. Nuclear factorkappaB activates dual inhibition sites in the regulation of tumor necrosis factor-alpha-induced neutrophil apoptosis. European Journal of Pharmacology 407: 211-219.
25. Michael, T.G., B. Karim, J.C. Mitchell, A.S. Lisa, C.W. Mary, L.S. Gregory, and P. Jean-Francois. 2007. Role of the alternative pathway in the early complement activation following major trauma. Shock 28: 29-34.
26. Guo, R.F., and P.A. Ward. 2005. Role of C5a in inflammatory responses. Annual Review of Immunology 23: 821-852.
27. Drouin, S.M., J. Kildsgaard, J. Haviland, J. Zabner, H.P. Jia, P.B.J. McCray, B.F. Tack, and R.A. Wetsel. 2001. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. Journal of Immunology 166: 2025-2032.
28. Ward, P.A. 1996. Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury. The American Journal of Pathology 149: 1081-1086.
29. Gustavo, M.B., W.F. Charles, and R.M. Thomas. 2008. Animal models of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 295: 379-399.